⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

May 1, 2024Open Access

Supplementary Figure S4 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials

Rebecca Svanberg Teglgaard Hanne Vibeke Marquart Hans Jakob Hartling Jakob Thaning Bay Caspar da Cunha‐Bang Christian Brieghel Tereza Faitová Lisbeth Enggaard Arnon P. Kater Mark‐David Levin Sabina Kersting Sisse Rye Ostrowski Carsten Utoft Niemann

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplementary Figure S4. Changes in immune cell activation marker expression during targeted treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Teglgaard et al. (2024) studied this question.

synapsesocial.com/papers/68e6c4b3b6db643587643643 https://doi.org/10.1158/1078-0432.25728700.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S4 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials2024
2Supplementary Figure S3 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials2024
3Supplementary Figure S3 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials2024
4Supplementary Figure S5 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials2024
5Supplementary Figure S5 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials2024
6Supplementary Figure S6 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials2024
7Supplementary Figure S6 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials2024
8Supplementary Figure S1 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials2024